Heart Failure Solutions, a clinical-stage medtech company based outside Minneapolis, recently announced the first successful in-human use of its PeriCut system, designed to treat patients with heart failure with preserved ejection fraction (HFpEF). The in-human use of the system was a part of Heart Failure Solutions’ FDA-approved early … [Read more...] about Heart Failure Solutions system has first in-human use
